The FDA approved orforglipron (Foundayo) in April 2026 — the first oral small-molecule GLP-1 agonist for weight management. No needles, no food restrictions, and significantly lower cost than injectable alternatives.
Semaglutide has reshaped medicine's approach to obesity, type 2 diabetes, and cardiovascular risk in a way few drugs have. Sold as Ozempic for diabetes and Wegovy for weight management, it is now one of the most prescribed medications in the United States — and one of the most discussed.
BPC-157 is a synthetic 15-amino-acid peptide derived from human gastric juice with remarkable healing properties. This guide covers mechanisms, benefits for gut healing, tendons, and brain health, plus evidence-based dosing protocols.
Of all the peptides in the research landscape, few are as biologically fundamental as kisspeptin. Discovered in 1996 and initially named for Hershey, Pennsylvania (home of the Hershey Kiss), kisspeptin turned out to be the master switch for human reproduction — the upstream signal that determines whether the entire hypothalamic-pituitary-gonadal (HPG)
A new class of metabolic compound is quietly gaining traction in biohacking and longevity circles: 5-Amino-1MQ. Unlike GLP-1 agonists that suppress appetite or stimulants that rev up the nervous system, 5-Amino-1MQ targets a specific enzyme deep inside fat cells — one that may be a master regulator of metabolic dysfunction. Here&